title: Can we afford the war on cancer?
abstract: Immunotherapy vaccines could extend survival in a handful of cancers. But personalizing treatment, payers argue, is not sustainable. Where should the line be drawn?
authors.forename: Ed
authors.initials: E
authors.lastname: Silverman